IFNβ-1a (N= 65) | IFNβ-1b (N= 64) | p-value | |
---|---|---|---|
MSTSQ assessments | |||
MSTSQ overall satisfaction score,a mean (SD) | 1.51 (0.56) | 1.53 (0.63) | 0.616 |
MSTSQ injection system score,a mean (SD) | 1.68 (0.41) | 1.80 (0.45) | 0.156 |
MSTSQ score for background information,a mean (SD) | 2.28 (0.91) | 2.28 (0.86) | 0.734 |
Blinded assessment of ISRs | |||
Diameter of injection-site redness, mm, mean (SD) | 11.32 (14.88) | 11.75 (15.53) | 0.986 |
Patients, n (%), with: | |||
Injection-site swelling | 19 (29.2) | 16 (25.0) | 0.848 |
Injection-site bruising | 21 (32.3) | 7 (10.9) | 0.019 |
Injection-site itching | 7 (10.8) | 6 (9.4) | 0.366 |
SF-MPQ assessments | |||
SF-MPQ VAS pain score,b mm, mean (SD) | 2.54 (7.98) | 3.24 (8.78) | 0.612 |
Patients pain-free on SF-MPQ VAS,b,c n (%) | 17 (26.2) | 17 (26.6) | 0.852 |